Flow Cytometric Immunophenotypic Analysis of 306 Cases of Multiple Myeloma
- 1 April 2004
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 121 (4) , 482-488
- https://doi.org/10.1309/74r4-tb90-buwh-27jx
Abstract
Bone marrow aspirates from 306 patients with multiple myeloma were analyzed by flow cytometric immunophenotyping. The plasma cells (PCs) were identified by their characteristic light scatter distribution and reactivity patterns to CD138, CD38, and CD45. Monoclonality was confirmed by immunoglobulin light chain analysis. The immunophenotypic profile of the PCs was determined with a panel of antibodies. Moderate to bright expression of CD56, CD117, CD20, CD45, and CD52 was detected in 71.7%, 17.8%, 9.3%, 8.8%, and 5.2% of cases, respectively. These antigens were expressed by a distinct subpopulation of the PCs in 6.3%, 2.2%, 3.7%, 2.9%, and 2.6% of additional cases. CD19 was negative in more than 99% of cases. The combination of CD38 and CD138 was superior to CD38 alone for identifying CD45+ myeloma and separating CD20+ myeloma from B-cell lymphoma. PC immunophenotyping might be useful for detecting minimal residual disease in cases with aberrant antigen expression and for selection of therapeutic agents that have specific membrane targets.Keywords
This publication has 15 references indexed in Scilit:
- Expression of CD52 on plasma cells in plasma cell proliferative disordersBlood, 2003
- Clinicopathological and prognostic characteristics of CD56‐negative multiple myelomaBritish Journal of Haematology, 2002
- Expression of CD56/Neural Cell Adhesion Molecule Correlates with the Presence of Lytic Bone Lesions in Multiple Myeloma and Distinguishes Myeloma from Monoclonal Gammopathy of Undetermined Significance and Lymphomas with Plasmacytoid DifferentiationThe American Journal of Pathology, 2002
- Differential expression of CD56 and CD44 in the evolution of extramedullary myelomaBritish Journal of Haematology, 2002
- Syndecan-1 (CD138) Immunoreactivity in Bone Marrow Biopsies of Multiple Myeloma: Shed Syndecan-1 Accumulates in Fibrotic RegionsLaboratory Investigation, 2001
- Immunophenotypic Aberrations, DNA Content, and Cell Cycle Analysis of Plasma Cells in Patients with Myeloma and Monoclonal GammopathiesBlood Cells, Molecules, and Diseases, 2000
- Syndecan-1 Expression on Malignant Cells from the Blood and Marrow of Patients with Plasma Cell Proliferative Disorders and B-Cell Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1998
- Expression of the CD117 antigen (C‐Kit) on normal and myelomatous plasma cellsBritish Journal of Haematology, 1996
- A plasmocyte selective monoclonal antibody (B‐B4) recognizes syndecan‐1British Journal of Haematology, 1996
- Cytoplasmic immunoglobulin content in multiple myeloma.Journal of Clinical Investigation, 1985